Applied Therapeutics Inc [NASDAQ: APLT] gained 30.19% on the last trading session, reaching $0.28 price per share at the time.
Applied Therapeutics Inc represents 144.30 million in outstanding shares, while the company has a total market value of $41.01 million with the latest information. APLT stock price has been found in the range of $0.2211 to $0.4.
If compared to the average trading volume of 6.26M shares, APLT reached a trading volume of 311195609 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Applied Therapeutics Inc [APLT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for APLT shares is $1.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on APLT stock is a recommendation set at 2.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Applied Therapeutics Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on December 23, 2024. While these analysts kept the previous recommendation, UBS raised their target price from $13 to $2. The new note on the price target was released on December 02, 2024, representing the official price target for Applied Therapeutics Inc stock. Previously, the target price had yet another drop from $12 to $4, while RBC Capital Mkts kept a Sector Perform rating on APLT stock.
Trading performance analysis for APLT stock
Applied Therapeutics Inc [APLT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -66.17. With this latest performance, APLT shares dropped by -77.80% in over the last four-week period, additionally sinking by -37.66% over the last 6 months – not to mention a drop of -66.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APLT stock in for the last two-week period is set at 28.41, with the RSI for the last a single of trading hit 0.1831, and the three-weeks RSI is set at 0.1602 for Applied Therapeutics Inc [APLT]. The present Moving Average for the last 50 days of trading for this stock 0.8658, while it was recorded at 0.5205 for the last single week of trading, and 0.5543 for the last 200 days.
Applied Therapeutics Inc [APLT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Applied Therapeutics Inc [APLT] shares currently have an operating margin of -9840.30% and a Gross Margin at 59.60%. Applied Therapeutics Inc’s Net Margin is presently recorded at -1813.80%.
Applied Therapeutics Inc (APLT) Capital Structure & Debt Analysis
According to recent financial data for Applied Therapeutics Inc. ( APLT), the Return on Equity (ROE) stands at -680.47%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -25.74%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Applied Therapeutics Inc’s Return on Invested Capital (ROIC) is -1232.20%, showcasing its effectiveness in deploying capital for earnings.
Applied Therapeutics Inc (APLT) Efficiency & Liquidity Metrics
Applied Therapeutics Inc (APLT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Applied Therapeutics Inc. (APLT) effectively leverages its workforce, generating an average of -$518285.71 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.96% and a Quick Ratio of 0.96%, indicating strong ability to cover short-term liabilities.
Applied Therapeutics Inc [APLT]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Applied Therapeutics Inc posted 0.33/share EPS, while the average EPS was predicted by analysts to be reported at -0.17/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.5. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APLT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Applied Therapeutics Inc go to 26.45%.
An analysis of Institutional ownership at Applied Therapeutics Inc [APLT]
There are presently around $69.61%, or 73.82%% of APLT stock, in the hands of institutional investors. The top three institutional holders of APLT stocks are: FRANKLIN RESOURCES INC with ownership of 10.21 million shares, which is approximately 7.0753%. VR ADVISER, LLC, holding 9.54 million shares of the stock with an approximate value of $$44.57 million in APLT stocks shares; and VR ADVISER, LLC, currently with $$37.38 million in APLT stock with ownership which is approximately 5.5457%.
